FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Spencer

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Leukocytes, Mononuclear

Physiology

Genetic Predisposition to Disease

Co-author Network

Publications

TOP 3
Michael Dickinson; David Ritchie; Daniel J DeAngelo; Andrew Spencer; Oliver G Ottmann; Thomas Fischer; Kapil N Bhalla; Angela Liu; Katie Parker; Jeffrey W Scott; Mark J Bishton; H Miles Prince
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.
A Kalff; J Shortt; J Farr; R McLennan; A Lui; J Scott; Andrew Spencer
Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia.
Max Wolf; Mark Bentley; Paula Marlton; Noemi Horvath; Ian D Lewis; Andrew Spencer; Richard Herrmann; Chris Arthur; Simon Durrant; Marilyn van Kerkhoven; Jamie MacMillan; Robert Mrongovius
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Spencer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Michael Dickinson; David Ritchie; Daniel J DeAngelo; Andrew Spencer; Oliver G Ottmann; Thomas Fischer; Kapil N Bhalla; Angela Liu; Katie Parker; Jeffrey W Scott; Mark J Bishton; H Miles Prince
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.
British journal of haematology 2009;147(1):97-101.
2008: A Kalff; J Shortt; J Farr; R McLennan; A Lui; J Scott; Andrew Spencer
Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia.
Haematologica 2008;93(1):e16-7.
2006: Max Wolf; Mark Bentley; Paula Marlton; Noemi Horvath; Ian D Lewis; Andrew Spencer; Richard Herrmann; Chris Arthur; Simon Durrant; Marilyn van Kerkhoven; Jamie MacMillan; Robert Mrongovius
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(11):2344-50.
2006: J Shortt; Andrew Spencer
Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma.
Bone marrow transplantation 2006;38(6):433-6.
2005: Andrew Spencer; N Horvath; John Gibson; H M Prince; Richard Herrmann; John Bashford; David Joske; Andrew Grigg; J McKendrick; I Prosser; Raymond Lowenthal; Sandra Deveridge; K Taylor
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.
Bone marrow transplantation 2005;35(10):971-7.
2004: Lisa Lincz; Ian Kerridge; Fiona E Scorgie; Michael Bailey; Arno Enno; Andrew Spencer
Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
Haematologica 2004;89(5):628-9.
2004: Andrew Spencer; Michael Seldon; Sandra Deveridge; Ralph Cobcroft; Gavin Cull; Paula Marlton; Arno Enno; Devinder Gill
Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(3):216-21.
2003: Lisa Lincz; Fiona E Scorgie; Ian Kerridge; Rachelle Potts; Andrew Spencer; Arno Enno
Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma.
British journal of haematology 2003;120(6):1051-4.
2002: Ian Kerridge; Lisa Lincz; Fiona E Scorgie; Danica Hickey; Neil Granter; Andrew Spencer
Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.
British journal of haematology 2002;118(2):477-81.
2001: Lisa Lincz; T X Yeh; Andrew Spencer
TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
Leukemia 2001;15(10):1650-7.
2001: Lisa Lincz; R L Crooks; S L Way; Neil Granter; Andrew Spencer
Tumour kinetics in multiple myeloma before, during, and after treatment.
Leukemia & lymphoma 2001;40(3-4):373-84.
1998: Andrew Spencer; Neil Granter; K Fagan; G Zaunders; Sandra Deveridge
Collection and analysis of peripheral blood mononuclear cells during haemopoietic recovery following PBSCT for CML: autografting as an in vivo purging manoeuvre?
Bone marrow transplantation 1998;21(1):101-3.